What is the maximum recommended daily dose of pregabalin?

Maximum Dose of Pregabalin

The maximum recommended daily dose of pregabalin is 600 mg/day in adults, administered as either 200 mg three times daily or 300 mg twice daily, with dose reduction required in patients with renal impairment. 1, 2

Dosing by Indication in Adults

Neuropathic Pain Conditions

• Diabetic Peripheral Neuropathy: Maximum 300 mg/day (100 mg three times daily), as doses above this provide no additional benefit and increase adverse effects 2

• Postherpetic Neuralgia: Maximum 600 mg/day (300 mg twice daily or 200 mg three times daily), though 300 mg/day is effective for most patients 1, 2

  • Reserve doses above 300 mg/day only for patients with ongoing pain who tolerate the lower dose 2

• General Neuropathic Pain: Maximum 600 mg/day, but higher doses are not consistently more effective than 300 mg/day and carry greater adverse event rates 1

Fibromyalgia

• Maximum dose: 450 mg/day (225 mg twice daily), though some sources cite 600 mg/day 2
• Start at 150 mg/day and increase to 300 mg/day within one week 2

Epilepsy (Adjunctive Therapy)

• Adults: Maximum 600 mg/day in 2-3 divided doses 1, 2
• Efficacy demonstrated across 150-600 mg/day range, with dose-response relationship 2

Pediatric Dosing (Epilepsy)

Children ≥30 kg (4-16 years)

• Maximum: 10 mg/kg/day (not to exceed 600 mg/day) 2, 3
• Administer in 2-3 divided doses 2

Children <30 kg

• Maximum: 14 mg/kg/day (requires 40% higher dose per kg due to higher weight-normalized clearance) 2, 3
• Children 1 month to <4 years: 3 divided doses 2
• Children ≥4 years: 2-3 divided doses 2

Critical Dosing Considerations

Renal Impairment

• Mandatory dose reduction required as pregabalin is eliminated primarily by renal excretion 1, 2
• Adjust based on creatinine clearance 1

Efficacy vs. Tolerability Trade-off

• 300 mg/day is the optimal dose for most neuropathic pain conditions, balancing efficacy and tolerability 1
• Doses of 600 mg/day show increased adverse events (somnolence 15-25%, dizziness 27-46%) without proportional benefit 1, 4
• Treatment discontinuation due to adverse events occurs in 18-28% at 600 mg/day 4

Titration Requirements

• Gradual titration reduces dose-dependent dizziness and sedation 1
• Typical schedule: Start 150 mg/day, increase to 300 mg/day after 1 week, then to 600 mg/day if needed over subsequent weeks 1

Discontinuation

• Taper gradually over minimum 1 week when discontinuing to avoid withdrawal symptoms 2, 5

Common Pitfall

Do not exceed 600 mg/day in any indication—this is the absolute maximum approved dose, and higher doses increase adverse events without improving efficacy and may indicate potential misuse 2, 6. Patients receiving doses above 600 mg/day are more likely to have substance use disorder history 6.